Clinical Trials Transformation Initiative
Outstanding Contribution to Health Award
The Clinical Trials Transformation Initiative (CTTI), cofounded by Duke University and the U.S. Food and Drug Administration (FDA), and hosted by Duke, identifies and promotes practices that will increase the quality and efficiency of clinical trials. CTTI executes its mission through the conduct of projects that generate empirical data and lead to consensus-driven, evidence-based recommendations for improving trials.
2016 Inspire Award Winners
-
Drugs for Neglected Diseases initiative • President’s Award for Outstanding Contribution to Global Health
-
Toshiyoshi Tominaga,
PhD • Global Connector Award -
Isabel Drzewiecki • Excellence in Service Award
-
Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials • Authors of the Year Award